Zwitterionic Block Copolymer for Gene Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current non-viral gene delivery systems face inefficiencies due to poor DNA transport across cell membranes, cytotoxicity issues, and instability of polymeric complexes, which limits their effectiveness and safety for genetic therapies.
Innovation Solution
A block copolymer composition with pendant zwitterionic groups and ionic blocks is developed, allowing for electrostatic binding with biologically active compounds like nucleic acids, forming stable particles less than 150 nm in size that can be taken up by cells without cytotoxicity, enhancing gene delivery efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If cationic polymers such as poly-L-lysine, polyethylenimine, or polyamidoamine dendrimer are used to facilitate gene delivery by neutralizing DNA charges, then DNA transport across cell membranes is improved, but cytotoxicity increases due to the proton sponge effect
Solution Approach 1:
The patent changes the chemical parameters of the polymer by using quaternized polymers with permanently charged groups instead of protonatable amine groups. This parameter change eliminates the pH-dependent proton sponge effect while maintaining the cationic charge necessary for DNA complexation and cellular uptake, thereby resolving the contradiction between delivery efficiency and cytotoxicity
Solution Approach 2:
The patent employs composite polymer structures combining hydrophobic and hydrophilic segments, such as poly(quinuclidine ethyl methacrylate)-block-poly(ethylene glycol) (PQEMA-b-PEO). This composite structure provides both the cationic charge for DNA binding and the hydrophilic PEO segments for biocompatibility and reduced cytotoxicity, simultaneously achieving efficient gene delivery and reduced cellular damage
2Productivity
If the size of conjugated particles is reduced to under 150 nm for effective cellular engulfment, then cell uptake efficiency is improved, but the stability and dispersability of particles in aqueous solution may deteriorate
Solution Approach 1:
The patent uses the hydrophilic polymer blocks (such as PEO or poly(N-isopropylacrylamide)) as flexible protective shells surrounding the cationic core that complexes with DNA. These flexible hydrophilic shells provide steric stabilization to small particles, preventing aggregation and maintaining colloidal stability in aqueous solutions while allowing the particles to remain below 150 nm for efficient cellular uptake
Solution Approach 2:
The block copolymer structure creates composite particles with a cationic hydrophobic core for DNA complexation and a hydrophilic outer shell for aqueous stability. This composite architecture enables small particle size for cellular internalization while the hydrophilic shell prevents aggregation and maintains dispersability in physiological conditions
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The block copolymer system effectively stabilizes biologically active compounds, enabling efficient intracellular delivery and reducing cytotoxicity, thus improving the prospects for gene therapy applications.
Implementation Method 1
A block copolymer composition with pendant zwitterionic groups and ionic blocks is developed, allowing for electrostatic binding with biologically active compounds like nucleic acids
Data Source
AI summary
Compositions are described comprising a of a block copolymer having an overall ionic charge and in which one of the blocks has pendant zwitterionic groups and a biologically active compound having a charge opposite that of the polymer. The polymer is preferably a linear diablock copolymer, preferably having a low polydispersity, such as a (tertiary amine group containing monomer) block-(zwitterionic monomer) copolymer. Suitable cationic monomers are dialkyl aminoalkyl(alk)acrylates and -acrylamides and suitable zwitterionic monomers are phosphorylcholine group containing acrylate monomers such as 2-methacyloyloxyetyl-21-trimethyl ammonium ethyl phosphate liner salt. The biologically active compound is generally polyionic and is for instance a nucleic acid, such as DNA, especially plasmid DNA.